These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28550801)

  • 61. Chronic non-peptide neurokinin receptor antagonist treatment alters striatal tachykinin peptide and receptor gene expression in the rat.
    McCarson KE; Krause JE; McLean S
    Neurosci Lett; 1998 Jul; 251(2):113-6. PubMed ID: 9718987
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
    Muñoz M; Coveñas R
    Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-acetyl-L-tryptophan, a substance-P receptor antagonist attenuates aluminum-induced spatial memory deficit in rats.
    Fernandes J; Mudgal J; Rao CM; Arora D; Basu Mallik S; Pai KSR; Nampoothiri M
    Toxicol Mech Methods; 2018 Jun; 28(5):328-334. PubMed ID: 29185389
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of Neurokinin-1 Receptor Signaling Pathways with Cancer.
    Rodriguez FD; Covenas R
    Curr Med Chem; 2024; 31(39):6460-6486. PubMed ID: 37594106
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NK-1 receptor antagonists: a new generation of anticancer drugs.
    Munoz M; Covenas R
    Mini Rev Med Chem; 2012 Jun; 12(7):593-9. PubMed ID: 22512565
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effectiveness of a single intraperitoneal infusion of a neurokinin-1 receptor antagonist in reducing postoperative adhesion formation is time dependent.
    Cohen PA; Aarons CB; Gower AC; Stucchi AF; Leeman SE; Becker JM; Reed KL
    Surgery; 2007 Mar; 141(3):368-75. PubMed ID: 17349849
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation.
    Cao X; Yang Y; Zhou W; Wang Y; Wang X; Ge X; Wang F; Zhou F; Deng X; Miao L
    BMC Cancer; 2023 May; 23(1):471. PubMed ID: 37221457
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression.
    Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M
    Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation.
    Garcia-Recio S; Pastor-Arroyo EM; Marín-Aguilera M; Almendro V; Gascón P
    PLoS One; 2015; 10(6):e0129661. PubMed ID: 26114632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
    Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.
    Koon HW; Zhao D; Zhan Y; Rhee SH; Moyer MP; Pothoulakis C
    J Immunol; 2006 Apr; 176(8):5050-9. PubMed ID: 16585602
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
    Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
    Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers.
    Li G; Yu K; Li F; Xu K; Li J; He S; Cao S; Tan G
    J Ethnopharmacol; 2014 Apr; 153(2):521-30. PubMed ID: 24631140
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Substance P Promotes the Progression of Endometrial Adenocarcinoma.
    Ma J; Yuan S; Cheng J; Kang S; Zhao W; Zhang J
    Int J Gynecol Cancer; 2016 Jun; 26(5):845-50. PubMed ID: 27051050
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and in vitro activities of NK-1 antagonists derived from L-tryptophan.
    Caliendo G; Fiorino F; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Albrizio S
    Farmaco; 1997 Oct; 52(10):589-93. PubMed ID: 9507670
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors.
    Kolorz J; Demir S; Gottschlich A; Beirith I; Ilmer M; Lüthy D; Walz C; Dorostkar MM; Magg T; Hauck F; von Schweinitz D; Kobold S; Kappler R; Berger M
    Curr Oncol; 2021 Dec; 29(1):94-110. PubMed ID: 35049682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The effect of NK-1 tachykinin receptor antagonist on hypoxia induced hepatic function injury and hepatocellular apoptosis in rats].
    Deng H; Luo F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Oct; 28(5):992-6. PubMed ID: 22097270
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines.
    Muñoz M; Rosso M; Pérez A; Coveñas R; Rosso R; Zamarriego C; Soult JA; Montero I
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2567-70. PubMed ID: 15980249
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of neurokinin-1 receptor antagonists.
    Muñoz M; Coveñas R
    Expert Opin Drug Saf; 2013 Sep; 12(5):673-85. PubMed ID: 23706125
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neurokinin-1 receptor antagonists protect mice from CD95- and tumor necrosis factor-alpha-mediated apoptotic liver damage.
    Bang R; Biburger M; Neuhuber WL; Tiegs G
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1174-80. PubMed ID: 14617692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.